Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.17EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.17ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.17ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.17EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.17EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CC.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CC.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CC.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CC.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CC.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CC.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BZ.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BZ.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BZ.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BZ.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BZ.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BZ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BZ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CK.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CK.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CK.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CK.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CK.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CK.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CK.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.1.13EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.1.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.13ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.1.1.13ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.1.1.13EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.1.1.13EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.1.1.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.1.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EF.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
EF.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EF.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
EF.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EF.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EF.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EF.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EF.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XPEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XPEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used